Assessment of the Pharmacokinetics of a Sustained Release Formulation of a Tramadol/Acetaminophen Combination
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
1. Objective: To evaluate the pharmacokinetic profiles of an SR 75 mg tramadol/650 mg
acetaminophen formulation compared with an immediate release (IR) 37.5 mg tramadol/325
mg acetaminophen formulation after a single dose and at steady state
2. Subjects: Healthy subject
3. Methods: A phase I study to evaluate the pharmacokinetic sustained release and immediate
release treatment profiles at steady state.